Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients.

Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients.
复制标题

DOI:
10.1016/j.vaccine.2023.01.033
复制
发表时间:
2023-02-24
期刊:
影响因子:
5.5
通讯作者:
Norton, Elizabeth B.
Norton, Elizabeth B.
中科院分区:
医学3区
文献类型:
--
作者:
Stone, Addison E.;Rambaran, Saraswatie;V. Trinh, Ivy;Estrada, Marcus;Jarand, Curtis W.;Williams, Blake S.;Murrell, Amelie E.;Huerter, Chelsea M.;Bai, William;Palani, Surya;Nakanishi, Yukihiro;Laird, Renee M.;Poly, Frederic M.;Reed, Wayne F.;White, Jessica A.;Norton, Elizabeth B.

文献摘要

参考文献

被引文献

相似文献

疫苗效力的一个关键方面是制剂稳定性。生化评估提供了有关最佳组成或热稳定性的信息,但通常通过离体分析进行验证,而不是在动物模型中的功效。在这里,我们评估了在脊髓灰质炎和肠出血性大肠杆菌中研究的提高或降低粘膜佐剂dmLT稳定性的制剂。大肠杆菌(ETEC)临床疫苗。我们观察到dmLT蛋白在制剂或热强制降解下的生物化学变化,包括聚集或亚基解离,或者特定缓冲液组合物对这些变化的抗性。然而,在用ETEC菌毛粘附素蛋白或灭活脊髓灰质炎病毒注射或粘膜接种后,实验结果表明免疫途径和共同施用的抗原对疫苗免疫原性的影响大于dmLT制剂稳定性(或不稳定性)。这些结果表明,生物化学和疫苗衍生的免疫评估在配方优化中的重要性。此外,这些研究对在临床环境中使用dmLT和在资源贫乏环境中提供有意义。
A key aspect to vaccine efficacy is formulation stability. Biochemical evaluations provide information on optimal compositions or thermal stability but are routinely validated by ex vivo analysis and not efficacy in animal models. Here we assessed formulations identified to improve or reduce stability of the mucosal adjuvant dmLT being investigated in polio and enterotoxigenic E. coli (ETEC) clinical vaccines. We observed biochemical changes to dmLT protein with formulation or thermal stress, including aggregation or subunit dissociation or alternatively resistance against these changes with specific buffer compositions. However, upon injection or mucosal vaccination with ETEC fimbriae adhesin proteins or inactivated polio virus, experimental findings indicated immunization route and co-administered antigen impacted vaccine immunogenicity more so than dmLT formulation stability (or instability). These results indicate the importance of both biochemical and vaccine-derived immunity assessment in formulation optimization. In addition, these studies have implications for use of dmLT in clinical settings and for delivery in resource poor settings.
DOI: 10.4049/jimmunol.1302743
发表时间: 2014-02-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Heine SJ;Diaz-McNair J;Andar AU;Drachenberg CB;van de Verg L;Walker R;Picking WL;Pasetti MF
通讯作者: Pasetti MF
DOI: 10.1126/sciimmunol.abf1198
发表时间: 2021-09-10
期刊: Science immunology
影响因子: 24.8
作者:
Iwanaga N;Chen K;Yang H;Lu S;Hoffmann JP;Wanek A;McCombs JE;Song K;Rangel-Moreno J;Norton EB;Kolls JK
通讯作者: Kolls JK
DOI: 10.1016/j.vaccine.2016.04.055
发表时间: 2016-06-08
期刊: VACCINE
影响因子: 5.5
作者:
Lundgren, Anna;Jertborn, Marianne;Svennerholm, Ann-Mari
通讯作者: Svennerholm, Ann-Mari
DOI: 10.1016/j.vaccine.2015.05.071
发表时间: 2015-07-09
期刊: VACCINE
影响因子: 5.5
作者:
Karp, Christopher L.;Lans, Deborah;Rao, Raja
通讯作者: Rao, Raja
DOI: 10.1016/j.vaccine.2016.02.076
发表时间: 2016-06-03
期刊: VACCINE
影响因子: 5.5
作者:
Bourgeois, A. Louis;Wierzba, Thomas F.;Walker, Richard I.
通讯作者: Walker, Richard I.